These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
179 related items for PubMed ID: 8438480
1. Anti-CD4 monoclonal antibody-induced allograft survival is associated with a defect in interleukin-2-dependent T-cell activation. Pearson TC, Hamano K, Morris PJ, Wood KJ. Transplant Proc; 1993 Feb; 25(1 Pt 1):786-7. PubMed ID: 8438480 [No Abstract] [Full Text] [Related]
2. Interaction between CD4 and CD8 T cells determines graft outcome in monoclonal antibody-treated mice. Hamano K, Morris PJ, Wood KJ. Transplant Proc; 1993 Feb; 25(1 Pt 1):792-3. PubMed ID: 8438483 [No Abstract] [Full Text] [Related]
3. Immunologic characterization of murine cardiac allograft recipients with long-term graft survival due to anti-VCAM-1 or anti-CD4 monoclonal antibody therapy. Orosz CG, Bergese SD, Huang EH, Vanbuskirk AM. Transplant Proc; 1995 Feb; 27(1):387-8. PubMed ID: 7533414 [No Abstract] [Full Text] [Related]
4. A non-lymphocyte-depleting monoclonal antibody to the adhesion molecule LFA-1 (CD11a) prevents sensitization to alloantigens and effectively prolongs the survival of heart allografts. Nakakura EK, McCabe SM, Zheng B, Shorthouse RA, Scheiner TM, Blank G, Jardieu PM, Morris RE. Transplant Proc; 1993 Feb; 25(1 Pt 1):809-12. PubMed ID: 8438493 [No Abstract] [Full Text] [Related]
5. Prolongation in murine cardiac allograft survival with monoclonal antibodies to LFA-1, ICAM-1, and CD4. Jendrisak M, Jendrisak G, Gamero J, Mohanakumar T. Transplant Proc; 1993 Feb; 25(1 Pt 1):825-7. PubMed ID: 8094914 [No Abstract] [Full Text] [Related]
6. Mechanism of induction of transplantation tolerance using donor antigen and anti-CD4 monoclonal antibody. Wood KJ, Bushell AR, Darby CR, Pearson TC, West L, Morris PJ. Transplant Proc; 1991 Feb; 23(1 Pt 1):133-4. PubMed ID: 1990498 [No Abstract] [Full Text] [Related]
7. The induction of transplantation tolerance using donor antigen and CD4 monoclonal antibody. Pearson TC, Madsen JC, Morris PJ, Wood KJ. Transplant Proc; 1990 Aug; 22(4):1955-6. PubMed ID: 2389494 [No Abstract] [Full Text] [Related]
8. Stability of tolerance in mice generated by CD4 and CD8 monoclonal antibody treatment: cell transfer experiments. Chen Z, Cobbold S, Waldmann H, Metcalfe S. Transplant Proc; 1993 Feb; 25(1 Pt 1):790-1. PubMed ID: 8438482 [No Abstract] [Full Text] [Related]
9. Interleukin-10 eliminates anti-CD3 monoclonal antibody-induced mortality and prolongs heart allograft survival in inbred mice. Lowry RP, Konieczny B, Alexander D, Larsen C, Pearson T, Smith S, Narula S. Transplant Proc; 1995 Feb; 27(1):392-4. PubMed ID: 7879034 [No Abstract] [Full Text] [Related]
10. Bidirectional blockade of CD4 and major histocompatibility complex class II molecules: an effective immunosuppressive treatment in the mouse heart transplantation model. Ito H, Hamano K, Fukumoto T, Wood KJ, Esato K. J Heart Lung Transplant; 1998 May; 17(5):460-9. PubMed ID: 9628564 [Abstract] [Full Text] [Related]
11. Prevention of acute murine cardiac allograft rejection: anti-CD4 or anti-vascular cell adhesion molecule one monoclonal antibodies block acute rejection but permit persistent graft-reactive alloimmunity and chronic tissue remodelling. Orosz CG, Huang EH, Bergese SD, Sedmak DD, Birmingham DJ, Ohye RG, VanBuskirk AM. J Heart Lung Transplant; 1997 Sep; 16(9):889-904. PubMed ID: 9322138 [Abstract] [Full Text] [Related]
12. Induction of transplantation tolerance using a nondepleting anti-CD4 MAb and donor-specific transfusion before transplantation: evidence that a critical period of time is required for the development of immunological unresponsiveness. Saitovitch D, Bushell AR, Morris PJ, Wood KJ. Transplant Proc; 1995 Feb; 27(1):117-8. PubMed ID: 7878834 [No Abstract] [Full Text] [Related]
13. Anti-CD2 monoclonal antibodies synergize with anti-CD3 to prolong allograft survival and decrease cytokine production. Chavin KD, Qin L, Lin J, Kaplan AJ, Bromberg JS. Transplant Proc; 1993 Feb; 25(1 Pt 1):823-4. PubMed ID: 8094913 [No Abstract] [Full Text] [Related]
14. Effect of anti-VCAM-1 and anti-VLA-4 monoclonal antibodies on cardiac allograft survival and response to soluble antigens in mice. Isobe M, Suzuki J, Yagita H, Okumura K, Sekiguchi M. Transplant Proc; 1994 Apr; 26(2):867-8. PubMed ID: 7513478 [No Abstract] [Full Text] [Related]
15. Effects of exogenous IL-2 on tolerance induction by anti-ICAM-1 and anti-LFA-1 monoclonal antibodies. Isobe M, Suzuki J, Yamazaki S, Sekiguchi M. Transplant Proc; 1996 Apr; 28(2):1045-6. PubMed ID: 8623222 [No Abstract] [Full Text] [Related]
16. Prolonged survival of mouse cardiac allografts after CD4 or CD8 monoclonal antibody therapy is associated with selective intragraft cytokine protein expression: interleukin (IL)-4 and IL-10 but not IL-2 or interferon-gamma. Hancock W, Mottram PL, Purcell LJ, Han WR, Pietersz GA, McKenzie IF. Transplant Proc; 1993 Oct; 25(5):2937-8. PubMed ID: 8212290 [No Abstract] [Full Text] [Related]
17. Donor-type single MHC locus products combined with anti-CD4 MAb can induce tolerance to cardiac allografts which is dependent on active suppression. Saitovitch D, Morris PJ, Wood KJ. Transplant Proc; 1995 Feb; 27(1):119-20. PubMed ID: 7878844 [No Abstract] [Full Text] [Related]
18. A combination of anergic cells' adoptive transfer and rapamycin therapy prolongs cardiac allograft survival in mice. Cai Y, Tang XD, Zhou PJ. Scand J Immunol; 2005 Mar; 61(3):266-73. PubMed ID: 15787744 [Abstract] [Full Text] [Related]